Peptide Research Bulletin — August 2026
FDA vote, EMA guideline and ADA 2026: the peptide research of July 2026 in ten points, with source, author and date for each item. Research Use Only.
Peptide news
Knowledge base
EMA guideline on synthetic peptides (2026): what it means for the EU
Since 1 June 2026 a separate EMA guideline for synthetic peptides applies in the EU. What it covers, who it applies to and why RUO research peptides fall outside it.
Knowledge base
Peptides and anti-doping rules: the 2026 WADA Prohibited List explained
The 2026 WADA Prohibited List has applied since 1 January 2026. For research peptides, class S0 is decisive: any pharmacological substance without marketing authorisation is prohibited, and at all times. Semaglutide and tirzepatide are monitored, not prohibited. This article explains the classes, the 2026 changes and the most common misconceptions. Research Use Only.
Peptide news
Peptide Research Bulletin — July 2026
Peptide Research Bulletin July 2026: the peptide research of June 2026 in ten points, with source, author and date for each entry. Research Use Only.
Knowledge base
Peptides and wound healing: what the research shows
Diagram of the wound-healing phases (inflammation, proliferation, maturation) and the peptide targets under study — RUOInflammationProliferationMaturationThe phases of wound healing, schematically. Research
Knowledge base
Peptides and fatty liver (MASH): what the research shows
Update — 2026: survodutide-onderzoek bij MASH in fase 3 Het survodutide-onderzoek bij MASH heeft in 2026 een grote stap gezet.
Knowledge base
AI and the future of peptide design
Update 2026: AI-ontwerp toegepast op kankervaccins Het duidelijkste toepassingsgebied van AI-peptide-ontwerp in 2026 is het kankervaccin op maat. Een overzichtsartikel
Knowledge base
Peptides in cancer research: how researchers use them
Update 2026: AI en peptiden-kankeronderzoek komen samen In juli 2026 verscheen in Frontiers in Genetics een overzichtsartikel over kunstmatige intelligentie
Knowledge base
Peptides and recovery after stroke and brain injury: what the research shows
Diagram: from excitotoxicity and inflammation after brain injury to the studied peptide targets — RUOExcitotoxicityInflammationTargetspeptidesStudied targets, schematically. Research Use Only.
Knowledge base
The FDA and peptides: what is really going on (2026)
Update — 24 juli 2026: FDA-adviescommissie stemt over zeven peptiden BPC-157 en KPV — RUO-onderzoekspeptiden. Illustratief; geen therapeutische claim. Op